articleTop 1% cited

Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics

Journal of Hepatology · 2006 · Vol. 46(3) · pp. 474–481

Marı́a Varela✉(Universitat de Barcelona)María Isabel Real(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)Marta Burrel(Universitat de Barcelona)Alejandro Forner(Universitat de Barcelona)María Sala(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)Merçè Brunet(Centro de Investigación Biomédica en Red)Carmen Ayuso(Centro de Investigación Biomédica en Red)Lluı́s Castells(Vall d'Hebron Hospital Universitari)Xavier Montañá(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)Josep M. Llovet(Universitat de Barcelona)Jordi Bruix(Centro de Investigación Biomédica en Red)

View via DOI Publisher page

Hepatocellular Carcinoma Treatment and Prognosis Liver Disease Diagnosis and Treatment Hepatitis C virus researchHepatocellular carcinomaPharmacokineticsDoxorubicinDrugMedicinePharmacologyInternal medicineOncologyChemotherapy

MeSH terms

AgedAntibiotics, AntineoplasticDose-Response Relationship, DrugDoxorubicinFemaleCarcinoma, HepatocellularHumansInjections, Intra-ArterialLiver NeoplasmsMaleMicrospheresMiddle AgedChemoembolization, TherapeuticDrug Delivery SystemsTreatment Outcome

Citations

925

FWCI

15.07

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma